nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFBR1—age related macular degeneration	0.103	0.117	CbGpPWpGaD
Pimecrolimus—FKBP1A—ALK1 signaling events—TGFBR1—age related macular degeneration	0.07	0.0795	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFBR1—age related macular degeneration	0.0593	0.0673	CbGpPWpGaD
Pimecrolimus—MTOR—LKB1 signaling events—MAP2—age related macular degeneration	0.0481	0.0545	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—TGFBR1—age related macular degeneration	0.0402	0.0456	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—TGFBR1—age related macular degeneration	0.039	0.0443	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—TIMP3—age related macular degeneration	0.0388	0.044	CbGpPWpGaD
Pimecrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR1—age related macular degeneration	0.0351	0.0399	CbGpPWpGaD
Pimecrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFBR1—age related macular degeneration	0.0317	0.036	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—COL10A1—age related macular degeneration	0.0264	0.03	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.0216	0.0245	CbGpPWpGaD
Pimecrolimus—MTOR—eye—age related macular degeneration	0.0211	0.178	CbGeAlD
Pimecrolimus—MTOR—retina—age related macular degeneration	0.021	0.177	CbGeAlD
Pimecrolimus—MTOR—connective tissue—age related macular degeneration	0.0204	0.172	CbGeAlD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—SQSTM1—age related macular degeneration	0.0196	0.0223	CbGpPWpGaD
Pimecrolimus—FKBP1A—eye—age related macular degeneration	0.019	0.16	CbGeAlD
Pimecrolimus—FKBP1A—retina—age related macular degeneration	0.0189	0.159	CbGeAlD
Pimecrolimus—FKBP1A—connective tissue—age related macular degeneration	0.0183	0.154	CbGeAlD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.0172	0.0195	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.0158	0.018	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.0142	0.0161	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—SQSTM1—age related macular degeneration	0.0117	0.0133	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TLR4—age related macular degeneration	0.011	0.0124	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.00964	0.0109	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—CCL2—age related macular degeneration	0.00941	0.0107	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NMNAT1—age related macular degeneration	0.00917	0.0104	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—RDH8—age related macular degeneration	0.00917	0.0104	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.00908	0.0103	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—CCL2—age related macular degeneration	0.00853	0.00968	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—C9—age related macular degeneration	0.00838	0.00951	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—RPE65—age related macular degeneration	0.00801	0.00909	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CFI—age related macular degeneration	0.00727	0.00825	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CFHR3—age related macular degeneration	0.00676	0.00767	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—KDR—age related macular degeneration	0.00667	0.00757	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—ABCA4—age related macular degeneration	0.00646	0.00733	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RDH8—age related macular degeneration	0.00642	0.00729	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—KDR—age related macular degeneration	0.0063	0.00715	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—C2—age related macular degeneration	0.00602	0.00683	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—RHO—age related macular degeneration	0.00562	0.00638	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RPE65—age related macular degeneration	0.00561	0.00637	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—VEGFA—age related macular degeneration	0.00548	0.00622	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—SQSTM1—age related macular degeneration	0.00524	0.00595	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—RDH8—age related macular degeneration	0.00516	0.00585	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NMNAT1—age related macular degeneration	0.00516	0.00585	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CFH—age related macular degeneration	0.00504	0.00572	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CFB—age related macular degeneration	0.00488	0.00554	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—C9—age related macular degeneration	0.00488	0.00554	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00452	0.00513	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—RPE65—age related macular degeneration	0.00451	0.00511	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CFI—age related macular degeneration	0.00423	0.0048	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00411	0.00467	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RHO—age related macular degeneration	0.00394	0.00447	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CFHR3—age related macular degeneration	0.00394	0.00447	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.00368	0.00417	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ABCA4—age related macular degeneration	0.00363	0.00412	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RDH8—age related macular degeneration	0.00361	0.0041	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CST3—age related macular degeneration	0.00351	0.00399	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—C2—age related macular degeneration	0.00351	0.00398	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—VEGFA—age related macular degeneration	0.00347	0.00394	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—RHO—age related macular degeneration	0.00316	0.00359	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RPE65—age related macular degeneration	0.00316	0.00358	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFBR1—age related macular degeneration	0.00316	0.00358	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CFH—age related macular degeneration	0.00293	0.00333	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CFB—age related macular degeneration	0.00285	0.00323	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.00279	0.00317	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ABCA4—age related macular degeneration	0.00254	0.00289	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RHO—age related macular degeneration	0.00221	0.00251	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.00221	0.00251	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD36—age related macular degeneration	0.00201	0.00228	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.002	0.00227	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CST3—age related macular degeneration	0.00198	0.00224	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD36—age related macular degeneration	0.00193	0.00219	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—C3—age related macular degeneration	0.0019	0.00216	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—C3—age related macular degeneration	0.00182	0.00207	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CRP—age related macular degeneration	0.00181	0.00205	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—VEGFA—age related macular degeneration	0.00178	0.00203	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFBR1—age related macular degeneration	0.00177	0.00201	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—SQSTM1—age related macular degeneration	0.00174	0.00198	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TLR4—age related macular degeneration	0.00173	0.00197	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—APOE—age related macular degeneration	0.00169	0.00192	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—C3—age related macular degeneration	0.00127	0.00144	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFBR1—age related macular degeneration	0.00124	0.00141	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—APOE—age related macular degeneration	0.00118	0.00134	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD36—age related macular degeneration	0.00117	0.00133	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—KDR—age related macular degeneration	0.00116	0.00132	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.00115	0.0013	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SQSTM1—age related macular degeneration	0.00113	0.00128	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—C3—age related macular degeneration	0.00111	0.00126	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CRP—age related macular degeneration	0.00105	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TLR4—age related macular degeneration	0.00101	0.00115	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.001	0.00114	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL2—age related macular degeneration	0.000996	0.00113	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APOE—age related macular degeneration	0.000951	0.00108	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000807	0.000916	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—C3—age related macular degeneration	0.000716	0.000812	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APOE—age related macular degeneration	0.000666	0.000756	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—KDR—age related macular degeneration	0.000653	0.000741	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000639	0.000725	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL2—age related macular degeneration	0.00056	0.000635	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000413	0.000469	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000399	0.000452	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VEGFA—age related macular degeneration	0.00036	0.000408	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CD36—age related macular degeneration	0.00024	0.000272	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000211	0.00024	CbGpPWpGaD
